These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38134970)

  • 1. Two-year clinical outcomes of resorbable magnesium scaffold versus conventional drug-eluting stents in ST-segment elevation myocardial infarction: A propensity score matching analysis.
    Koliastasis L; Bennett J; Xaplanteris P; Skalidis I; Guédès A; Demeure F; Vandeloo B; Dugauquier C; Picard F; Warne DW; Pilgrim T; Iglesias JF; de Hemptinne Q
    Hellenic J Cardiol; 2024; 78():84-86. PubMed ID: 38134970
    [No Abstract]   [Full Text] [Related]  

  • 2. Magmaris Resorbable Magnesium Scaffold Versus Conventional Drug-Eluting Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity-Score-Matching Comparison.
    de Hemptinne Q; Xaplanteris P; Guédès A; Demeure F; Vandeloo B; Dugauquier C; Picard F; Warne DW; Pilgrim T; Iglesias JF; Bennett J
    Cardiovasc Revasc Med; 2022 Oct; 43():28-35. PubMed ID: 35641364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-Eluting Resorbable Magnesium Scaffold Implantation in ST-Segment Elevation Myocardial Infarction: A Pilot Study.
    de Hemptinne Q; Picard F; Briki R; Awada A; Silance PG; Dolatabadi D; Debbas N; Unger P
    J Invasive Cardiol; 2018 Jun; 30(6):202-206. PubMed ID: 29656279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).
    Brugaletta S; Gori T; Low AF; Tousek P; Pinar E; Gomez-Lara J; Scalone G; Schulz E; Chan MY; Kocka V; Hurtado J; Gomez-Hospital JA; Münzel T; Lee CH; Cequier A; Valdés M; Widimsky P; Serruys PW; Sabaté M
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):189-197. PubMed ID: 25616924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial.
    Sabaté M; Alfonso F; Cequier A; Romaní S; Bordes P; Serra A; Iñiguez A; Salinas P; García Del Blanco B; Goicolea J; Hernández-Antolín R; Cuesta J; Gómez-Hospital JA; Ortega-Paz L; Gomez-Lara J; Brugaletta S
    Circulation; 2019 Dec; 140(23):1904-1916. PubMed ID: 31553204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.
    Iglesias JF; Muller O; Heg D; Roffi M; Kurz DJ; Moarof I; Weilenmann D; Kaiser C; Tapponnier M; Stortecky S; Losdat S; Eeckhout E; Valgimigli M; Odutayo A; Zwahlen M; Jüni P; Windecker S; Pilgrim T
    Lancet; 2019 Oct; 394(10205):1243-1253. PubMed ID: 31488372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Polymeric Bioresorbable Vascular Scaffold Versus an Everolimus-Eluting Stent in ST-Segment Elevation Myocardial Infarction.
    Wernly B; Latib A; Ielasi A; Jung C
    J Invasive Cardiol; 2019 Sep; 31(9):E271-E272. PubMed ID: 31478894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study.
    Brugaletta S; Gori T; Tousek P; Gomez-Lara J; Pinar E; Ortega-Paz L; Schulz E; Kocka V; Münzel T; Cequier À; Buono A; Serruys PW; Sabaté M;
    EuroIntervention; 2020 Mar; 15(16):1436-1443. PubMed ID: 31845896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.
    Sabaté M; Windecker S; Iñiguez A; Okkels-Jensen L; Cequier A; Brugaletta S; Hofma SH; Räber L; Christiansen EH; Suttorp M; Pilgrim T; Anne van Es G; Sotomi Y; García-García HM; Onuma Y; Serruys PW
    Eur Heart J; 2016 Jan; 37(3):229-40. PubMed ID: 26405232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial.
    Iglesias JF; Muller O; Losdat S; Roffi M; Kurz DJ; Weilenmann D; Kaiser C; Heg D; Valgimigli M; Windecker S; Pilgrim T
    Int J Cardiol; 2021 Jul; 334():37-41. PubMed ID: 33887341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison.
    Brugaletta S; Gori T; Low AF; Tousek P; Pinar E; Gomez-Lara J; Ortega-Paz L; Schulz E; Chan MY; Kocka V; Hurtado J; Gomez-Hospital JA; Giacchi G; Münzel T; Lee CH; Cequier A; Valdés M; Widimsky P; Serruys PW; Sabaté M
    Int J Cardiol; 2016 Jul; 214():483-4. PubMed ID: 27096965
    [No Abstract]   [Full Text] [Related]  

  • 12. Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study.
    Fam JM; Felix C; van Geuns RJ; Onuma Y; Van Mieghem NM; Karanasos A; van der Sijde J; De Paolis M; Regar E; Valgimigli M; Daemen J; de Jaegere P; Zijlstra F; Diletti R
    EuroIntervention; 2016 May; 12(1):30-7. PubMed ID: 27173859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium-based bioresorbable scaffolds in STEMI. The quest for the optimal bioresorption balance.
    Gonzalo N; McInerney A
    EuroIntervention; 2020 Dec; 16(11):e869-e871. PubMed ID: 33274723
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved clinical outcome with biodegradable polymer drug-eluting stents compared to durable polymer drug-eluting stents for primary percutaneous coronary intervention.
    Andriyati R; Firman D; Kurniawati Y; Alkatiri AA; Pranata R; Muliawan HS; Rossimarina V; Soerianata S
    Postgrad Med J; 2021 Oct; 97(1152):638-643. PubMed ID: 32796116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI.
    Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Atherosclerosis; 2019 Jan; 280():166-173. PubMed ID: 30529829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of bioresorbable vascular scaffold in ST-elevation myocardial infarction.
    de Hemptinne Q; Picard F; Ly HQ; Ibrahim R; Asgar AW; de Guise P; Doucet S; Dorval JF; Marquis-Gravel G; Levi M; L-L'allier P; Tanguay JF
    Acta Cardiol; 2018 Jun; 73(3):276-281. PubMed ID: 28954592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.
    Yamaji K; Brugaletta S; Sabaté M; Iñiguez A; Jensen LO; Cequier A; Hofma SH; Christiansen EH; Suttorp M; van Es GA; Sotomi Y; Onuma Y; Serruys PW; Windecker S; Räber L
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1867-1877. PubMed ID: 28935079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial Baseline, 12-, 24-, and 60-Month Optical Coherence Tomography Evaluation of ST Segment Elevation Myocardial Infarction Patients Treated with Absorb Bioresorbable Vascular Scaffold.
    Koltowski L; Tomaniak M; Ochijewicz D; Zieliński K; Proniewska K; Malinowski KP; Zaleska M; Maksym J; Roleder T; Partyka L; Kochman W; Filipiak KJ; Opolski G; Kochman J
    Am J Cardiol; 2021 Sep; 155():23-31. PubMed ID: 34315572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?
    Vergallo R; Galiuto L
    Eur Heart J; 2024 May; 45(18):1593-1595. PubMed ID: 38437630
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term outcomes of delayed percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction: A propensity score-matched retrospective study.
    Xue YL; Ma YT; Gao YP; Zhang SX; Su QY; Li YF; Zhang L; Ding PF; Li XW
    Medicine (Baltimore); 2021 Nov; 100(46):e27474. PubMed ID: 34797274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.